Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models
Crossref DOI link: https://doi.org/10.1007/s11095-018-2400-y
Published Online: 2018-04-17
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schönfeld, Kurt
Herbener, Peter
Zuber, Chantal
Häder, Thomas
Bernöster, Katrin
Uherek, Christoph
Schüttrumpf, Jörg
Text and Data Mining valid from 2018-04-17
Article History
Received: 15 November 2017
Accepted: 3 April 2018
First Online: 17 April 2018